Int. J. Environ. Res. Public Health 2012, 9(12), 4744-4759; doi:10.3390/ijerph9124744
Review

Second Malignant Neoplasms Following Radiotherapy

Department of Radiation Oncology, Henry Ford Hospital, Detroit MI 48202, USA
Received: 10 October 2012; in revised form: 6 December 2012 / Accepted: 6 December 2012 / Published: 18 December 2012
(This article belongs to the Special Issue Radiation and Cancer Risk)
PDF Full-text Download PDF Full-Text [1085 KB, uploaded 18 December 2012 09:56 CET]
Abstract: More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy.
Keywords: radiation; second malignancy; cancer therapy; side effects; radiotherapy; neoplasm

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Kumar, S. Second Malignant Neoplasms Following Radiotherapy. Int. J. Environ. Res. Public Health 2012, 9, 4744-4759.

AMA Style

Kumar S. Second Malignant Neoplasms Following Radiotherapy. International Journal of Environmental Research and Public Health. 2012; 9(12):4744-4759.

Chicago/Turabian Style

Kumar, Sanath. 2012. "Second Malignant Neoplasms Following Radiotherapy." Int. J. Environ. Res. Public Health 9, no. 12: 4744-4759.

Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert